View in EDS PDF Full Text

PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.

Saved in:
Bibliographic Details
Title: PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
Authors: Barkdull S; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA., Brownell I; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA.
Source: Cancer biology & therapy [Cancer Biol Ther] 2017 Dec 02; Vol. 18 (12), pp. 937-939. Date of Electronic Publication: 2017 Nov 27.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29172995
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Barkdull+S%22">Barkdull S</searchLink>; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA.<br /><searchLink fieldCode="AU" term="%22Brownell+I%22">Brownell I</searchLink>; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101137842%22">Cancer biology & therapy</searchLink> [Cancer Biol Ther] 2017 Dec 02; Vol. 18 (12), pp. 937-939. <i>Date of Electronic Publication: </i>2017 Nov 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101137842 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1555-8576 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215384047%22">15384047 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Biol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29172995
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/15384047.2017.1394552
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 937
    Titles:
      – TitleFull: PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Barkdull S
      – PersonEntity:
          Name:
            NameFull: Brownell I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2017 Dec 02
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1555-8576
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Cancer biology & therapy
              Type: main
ResultId 1